Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03409653
Other study ID # H16-01648
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date June 12, 2017
Est. completion date September 30, 2025

Study information

Verified date February 2023
Source BC Women's Hospital & Health Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this data registry is to prospectively collect data from patients referred to an Complex Chronic Diseases Program (CCDP) at BC Women's Hospital + Health Centre to assess the quality of life of the CCDP Patients before, during and after their care at the CCDP.


Description:

1. Before their initial intake appointment, all CCDP patients are given a patient binder that includes the baseline Standardized Questionnaires. These are clinical questionnaires that all patients complete regardless of whether or not they consent to participation in research. In addition to the questionnaires completed at baseline, patients who consent to participate in the data registry will complete the questionnaires, via email or paper copy, at the following time points: approximately 6 months after intake, at discharge and 3 months post-discharge. 2. Patients who consent to the data registry will also be asked to complete a short questionnaire collecting basic demographic information at baseline. The demographic questionnaire will be either mailed to their home or sent via an online link; the investigators will ask participants to complete this form either before or when they come in for their first in-person visit at the CCDP. 3. Additional data will be collected and entered from the clinical chart. Specifically, after the patient's initial clinic appointment, the Research Coordinator or designate will enter data points from the Interdisciplinary Assessment Tool, into REDCap.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 1300
Est. completion date September 30, 2025
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Newly referred patients of the Complex Chronic Diseases Program - Must be able to read and understand English - 18 years of age or older Exclusion Criteria: - Have not completed the Standardized Questionnaires booklet prior to the initial intake assessment.

Study Design


Locations

Country Name City State
Canada BC Women's Hospital + Health Centre Vancouver British Columbia

Sponsors (2)

Lead Sponsor Collaborator
BC Women's Hospital & Health Centre Ministry of Health, Province of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in quality of life Change in self-reported quality of life assessed by structured questionnaire (36 Item Short Form Health Survey (SF-36)) Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
Secondary Brief Pain Inventory Short Form (BPI-SF) The BPI-SF is a self-reported standard questionnaire used to evaluate the severity of pain and the impact of this pain on the patient's daily functioning. Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
Secondary Fatigue Severity Scale (FSS) The FSS is a self-reported standard questionnaire that uses a scale to measures the severity of the fatigue and its effect on a person's activities and lifestyles in patients with a variety of disorders. It uses a 7- point Liker scale, where 1=Strongly Disagree and 7= Strongly agree. Score range is 1-7. Higher schore indicates more severe fatigue. Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
Secondary McGill Pain Questionnaire Short Form The McGill Pain Questionnaire Short Form is self-reported standard questionnaire. It is used to describes the subjective overall intensity of the total pain experience. Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
Secondary Pittsburgh Sleep Quality Index (PSQI) The PSQI is a self-reported standard questionnaires. It is used to assess sleep quality and disturbances. Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
Secondary Patient Health Questionnaire 9 (PHQ - 9) The PHQ-9 is a self-reported standard questionnaire used to screen, diagnose, monitor and measure the severity of depression. Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
Secondary Generalized Anxiety Disorder - 7 item (GAD - 7) The GAD-7 is a self-reported standard questionnaire used to measures the severity of various signs of general anxiety disorder according to response categories with assigned points. Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05659862 - Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT03042728 - Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program N/A
Recruiting NCT06097091 - Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia N/A
Recruiting NCT04554784 - Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia N/A
Completed NCT03300635 - Metabolism, Muscle Function and Psychological Factors in Fibromyalgia N/A
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT03166995 - Postural Exercises in Women With Fibromyalgia N/A
Completed NCT03227952 - Sensory Stimulation in Fibromyalgia N/A
Recruiting NCT06237595 - Vagus Nerve Stimulation in Fibromyalgia N/A
Completed NCT01888640 - Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST) N/A
Completed NCT03641495 - Pain Education and Therapeutic Exercise for Fibromyalgia N/A
Recruiting NCT05581628 - FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
Active, not recruiting NCT05128162 - Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Phase 2
Completed NCT04674878 - Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia N/A
Active, not recruiting NCT04084795 - Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia N/A
Completed NCT03129906 - Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients N/A
Completed NCT05058911 - Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia N/A
Recruiting NCT04571853 - New Educational Tool for FM N/A
Recruiting NCT04571528 - Effectiveness of VIRTUAL FIBROWALK STUDY N/A